Cargando…
Efficacy of artemisinin–lumefantrine for treatment of uncomplicated malaria after more than a decade of its use in Kenya
Background The resistance of Plasmodium falciparum to antimalarial drugs remains a major impairment in the treatment and eradication of malaria globally. Following the introduction of artemisinin-based combination therapy (ACT), there have been reports of delayed parasite clearance. In Kenya, arteme...
Autores principales: | Kishoyian, Gabriel, Njagi, Eliud N. M., Orinda, George O., Kimani, Francis T., Thiongo, Kevin, Matoke-Muhia, Damaris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057502/ https://www.ncbi.nlm.nih.gov/pubmed/33397548 http://dx.doi.org/10.1017/S0950268820003167 |
Ejemplares similares
-
Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
por: Omondi, Protus, et al.
Publicado: (2019) -
Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
por: Mayxay, Mayfong, et al.
Publicado: (2012) -
Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
por: Moore, Brioni R., et al.
Publicado: (2017) -
Status of insecticide resistance in malaria vectors in Kwale County, Coastal Kenya
por: Kiuru, Caroline W., et al.
Publicado: (2018) -
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
por: Peto, Thomas J, et al.
Publicado: (2022)